article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

article thumbnail

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Daniel Veres, M.D.,

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

#099: Dr. David Fajgenbaum on Chasing a Cure for Rare Disease

Digital Health Today

It passed the House in July of 2015, but was not signed into law – largely because of the political stigma associated with anything that could be perceived as benefiting big pharma – when in reality this is needed to help thousands of people. Digital Health Today would not be possible without our valuable partners.

article thumbnail

Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.

Digital Health Global

a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI). Contacts Media Contact: Massive Bio Erkan Terzi Chief Marketing Officer +1 844 627 7246 pr@massivebio.com